Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2019

Open Access 01-12-2019 | Stroke | Research article

Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study

Authors: Alberto Maino, Ale Algra, Flora Peyvandi, Frits Richard Rosendaal, Bob Siegerink

Published in: BMC Cardiovascular Disorders | Issue 1/2019

Login to get access

Abstract

Background

We aimed to investigate the role of hypercoagulability on the risk of lifetime cardiovascular recurrences after myocardial infarction or ischaemic stroke.

Methods

Young women (< 50 years) with either myocardial infarction (n = 197) or ischaemic stroke (n = 107) were followed between 1995 and 2012 in the RATIO follow-up study. To determine whether hypercoagulability affects the risk or recurrence, a coagulation score based on acquired and inherited markers was compiled and used in a quartile analysis. Hazard ratios (HRs) obtained from Cox proportional models and adjusted for several cardiovascular risk factors were used to compare quartiles of the coagulation score for the risk of recurrence.

Results

During a median follow-up of 19 years, 59 cardiovascular recurrences occurred. In patients with myocardial infarction no association was found between a high prothrombotic score and recurrences (highest quartile vs lowest quartile HR 0.7, 95% CI, 0.3–1.8). Conversely, ischaemic stroke patients with a high prothrombotic score showed a doubling in risk of long-term cardiovascular recurrences (HR 1.9, 95% CI 0.6–6.3) compared with ischaemic stroke patients and low levels of the score, with a dose response relationship.

Conclusions

An increased coagulation tendency might be associated with long-term cardiovascular risk in women with ischaemic stroke, but not in women with myocardial infarction.
Literature
1.
go back to reference Hankey GJ. Stroke in young adults: implications of the long-term prognosis. JAMA. 2013;309(11):1171–2.CrossRef Hankey GJ. Stroke in young adults: implications of the long-term prognosis. JAMA. 2013;309(11):1171–2.CrossRef
2.
go back to reference Rutten-Jacobs LC, Maaijwee NA, Arntz RM, Schoonderwaldt HC, Dorresteijn LD, van der Vlugt MJ, van Dijk EJ, de Leeuw FE. Long-term risk of recurrent vascular events after young stroke: the FUTURE study. Ann Neurol. 2013;74(4):592–601.CrossRef Rutten-Jacobs LC, Maaijwee NA, Arntz RM, Schoonderwaldt HC, Dorresteijn LD, van der Vlugt MJ, van Dijk EJ, de Leeuw FE. Long-term risk of recurrent vascular events after young stroke: the FUTURE study. Ann Neurol. 2013;74(4):592–601.CrossRef
3.
go back to reference Cole JH, Miller JI 3rd, Sperling LS, Weintraub WS. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol. 2003;41(4):521–8.CrossRef Cole JH, Miller JI 3rd, Sperling LS, Weintraub WS. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol. 2003;41(4):521–8.CrossRef
4.
go back to reference Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council study group on stroke in the young. Stroke. 1999;30(11):2320–5.CrossRef Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council study group on stroke in the young. Stroke. 1999;30(11):2320–5.CrossRef
5.
go back to reference Kappelle LJ, Adams HP Jr, Heffner ML, Torner JC, Gomez F, Biller J. Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa registry of stroke in young adults. Stroke. 1994;25(7):1360–5.CrossRef Kappelle LJ, Adams HP Jr, Heffner ML, Torner JC, Gomez F, Biller J. Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa registry of stroke in young adults. Stroke. 1994;25(7):1360–5.CrossRef
6.
go back to reference Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, Delodovici ML, Paciaroni M, Del Sette M, Toriello A, et al. Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian project on stroke in young adults. Circulation. 2014;129(16):1668–76.CrossRef Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, Delodovici ML, Paciaroni M, Del Sette M, Toriello A, et al. Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian project on stroke in young adults. Circulation. 2014;129(16):1668–76.CrossRef
7.
go back to reference Cannegieter SC, van Hylckama Vlieg A. Venous thrombosis: understanding the paradoxes of recurrence. J Thromb Haemost. 2013;11(Suppl 1):161–9.CrossRef Cannegieter SC, van Hylckama Vlieg A. Venous thrombosis: understanding the paradoxes of recurrence. J Thromb Haemost. 2013;11(Suppl 1):161–9.CrossRef
8.
go back to reference Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305(8):822–3.CrossRef Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305(8):822–3.CrossRef
9.
go back to reference Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8(11):998–1005.CrossRef Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8(11):998–1005.CrossRef
10.
go back to reference Siegerink B, Maino A, Algra A, Rosendaal FR. Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women. J Thromb Haemost. 2015;13(9):1568–75.CrossRef Siegerink B, Maino A, Algra A, Rosendaal FR. Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women. J Thromb Haemost. 2015;13(9):1568–75.CrossRef
11.
go back to reference Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B. Hypercoagulability is a stronger risk factor for Ischaemic stroke than for myocardial infarction: a systematic review. PLoS One. 2015;10(8):e0133523.CrossRef Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B. Hypercoagulability is a stronger risk factor for Ischaemic stroke than for myocardial infarction: a systematic review. PLoS One. 2015;10(8):e0133523.CrossRef
12.
go back to reference Maino A, Siegerink B, Algra A, Peyvandi F, Rosendaal FR. Recurrence and mortality in young women with myocardial infarction or ischemic stroke: long-term follow-up of the risk of arterial thrombosis in relation to Oral contraceptives (RATIO) study. JAMA Intern Med. 2016;176(1):134–6.CrossRef Maino A, Siegerink B, Algra A, Peyvandi F, Rosendaal FR. Recurrence and mortality in young women with myocardial infarction or ischemic stroke: long-term follow-up of the risk of arterial thrombosis in relation to Oral contraceptives (RATIO) study. JAMA Intern Med. 2016;176(1):134–6.CrossRef
13.
go back to reference Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A. Risk of arterial thrombosis in relation to Oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33(5):1202–8.CrossRef Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A. Risk of arterial thrombosis in relation to Oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33(5):1202–8.CrossRef
14.
go back to reference Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, van der Graaf Y, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345(25):1787–93.CrossRef Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, van der Graaf Y, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345(25):1787–93.CrossRef
15.
go back to reference Van Den Bosch MA, Kemmeren JM, Tanis BC, Mali WP, Helmerhorst FM, Rosendaal FR, Algra A, Van Der Graaf Y. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost. 2003;1(3):439–44.CrossRef Van Den Bosch MA, Kemmeren JM, Tanis BC, Mali WP, Helmerhorst FM, Rosendaal FR, Algra A, Van Der Graaf Y. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost. 2003;1(3):439–44.CrossRef
16.
go back to reference Maino A, Siegerink B, Algra A, Martinelli I, Peyvandi F, Rosendaal FR. Pregnancy loss and risk of ischaemic stroke and myocardial infarction. Br J Haematol. 2016;174(2):302–9.CrossRef Maino A, Siegerink B, Algra A, Martinelli I, Peyvandi F, Rosendaal FR. Pregnancy loss and risk of ischaemic stroke and myocardial infarction. Br J Haematol. 2016;174(2):302–9.CrossRef
17.
go back to reference De Bruin AKJ, Gast F, de Bruin E, van Sijl M, Verweij G. Record linkage of hospital discharge register with population register: experiences at statistics Netherlands. Stat J United Nations Econ Commission Eur. 2004;21:23–32. De Bruin AKJ, Gast F, de Bruin E, van Sijl M, Verweij G. Record linkage of hospital discharge register with population register: experiences at statistics Netherlands. Stat J United Nations Econ Commission Eur. 2004;21:23–32.
18.
go back to reference Stricker BH, Herings RM. Plea for the retention of the Dutch National Medical Registration (LMR) to provide reliable information regarding public health and healthcare. Ned Tijdschr Geneeskd. 2006;150(35):1916–7.PubMed Stricker BH, Herings RM. Plea for the retention of the Dutch National Medical Registration (LMR) to provide reliable information regarding public health and healthcare. Ned Tijdschr Geneeskd. 2006;150(35):1916–7.PubMed
19.
go back to reference Siegerink B, Meltzer ME, de Groot PG, Algra A, Lisman T, Rosendaal FR. Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study. Br J Haematol. 2012;156(2):252–8.CrossRef Siegerink B, Meltzer ME, de Groot PG, Algra A, Lisman T, Rosendaal FR. Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study. Br J Haematol. 2012;156(2):252–8.CrossRef
20.
go back to reference Siegerink B, Rosendaal FR, Algra A. Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women. J Thromb Haemost. 2014;12(5):606–13.CrossRef Siegerink B, Rosendaal FR, Algra A. Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women. J Thromb Haemost. 2014;12(5):606–13.CrossRef
21.
go back to reference Siegerink B, Govers-Riemslag JW, Rosendaal FR, Ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the risk of arterial thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation. 2010;122(18):1854–61.CrossRef Siegerink B, Govers-Riemslag JW, Rosendaal FR, Ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the risk of arterial thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation. 2010;122(18):1854–61.CrossRef
22.
go back to reference Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, Rosendaal FR. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood. 2012;119(6):1555–60.CrossRef Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, Rosendaal FR. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood. 2012;119(6):1555–60.CrossRef
23.
go back to reference Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, Rosendaal FR. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol. 2003;122(3):471–8.CrossRef Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, Rosendaal FR. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol. 2003;122(3):471–8.CrossRef
24.
go back to reference Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost. 2005;3(6):1213–7.CrossRef Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost. 2005;3(6):1213–7.CrossRef
25.
go back to reference Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 1993, 24(1):35–41. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 1993, 24(1):35–41.
Metadata
Title
Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study
Authors
Alberto Maino
Ale Algra
Flora Peyvandi
Frits Richard Rosendaal
Bob Siegerink
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2019
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-1040-4

Other articles of this Issue 1/2019

BMC Cardiovascular Disorders 1/2019 Go to the issue